FDA Inspection 1011071 — M. Deshpande
The FDA completed an inspection of M. Deshpande on May 5, 2017 in Northwood, NA HA6 2RN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 5, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Northwood, NA HA6 2RN (United Kingdom)
Additional Details
Clinical Investigator (CI)